These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6428493)

  • 21. Canthaxanthin retinopathy. Anatomic and functional reversibility.
    Harnois C; Samson J; Malenfant M; Rousseau A
    Arch Ophthalmol; 1989 Apr; 107(4):538-40. PubMed ID: 2495787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversibility of canthaxanthin deposits within the retina.
    Leyon H; Ros AM; Nyberg S; Algvere P
    Acta Ophthalmol (Copenh); 1990 Oct; 68(5):607-11. PubMed ID: 2125796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Canthaxanthine retinopathy: 1. Clinical study in 51 consumers].
    Boudreault G; Cortin P; Corriveau LA; Rousseau AP; Tardif Y; Malenfant M
    Can J Ophthalmol; 1983 Dec; 18(7):325-8. PubMed ID: 6423246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Retinopathy due to canthazanthine: 2. Predisposing factors].
    Cortin P; Boudreault G; Rousseau AP; Tardif Y; Malenfant M
    Can J Ophthalmol; 1984 Aug; 19(5):215-9. PubMed ID: 6434169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gold dust retinopathy after the ingestion of canthaxanthine to produce skin-bronzing.
    McGuinness R; Beaumont P
    Med J Aust; 1985 Dec 9-23; 143(12-13):622-3. PubMed ID: 3938522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental carotenoid retinopathy. I. Functional and morphological alterations of the rabbit retina after 11 months dietary carotenoid application.
    Weber U; Kern W; Novotny GE; Goerz G; Hanappel S
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):198-205. PubMed ID: 3111945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Maculopathy with golden particles].
    Cortin P; Corriveau LA; Rousseau AP; Tardif Y; Malenfant M; Boudreault G
    Can J Ophthalmol; 1982 Jun; 17(3):103-6. PubMed ID: 6811115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal crystals and oral tanning agents.
    White GL; Beesley R; Thiese SM; Murdock RT
    Am Fam Physician; 1988 Mar; 37(3):125-6. PubMed ID: 3126629
    [No Abstract]   [Full Text] [Related]  

  • 29. [Carotinoid deposits in the retina].
    Philipp W
    Klin Monbl Augenheilkd; 1985 Nov; 187(5):439-40. PubMed ID: 3936971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental carotenoid retinopathy. II. Functional and morphological alterations of the rabbit retina after acute canthaxanthin application with small unilamellar phospholipid liposomes.
    Weber U; Michaelis L; Kern W; Goerz G
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(5):346-50. PubMed ID: 3117623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canthaxanthin toxicity.
    Herbert V
    Am J Clin Nutr; 1991 Feb; 53(2):573-4. PubMed ID: 1899175
    [No Abstract]   [Full Text] [Related]  

  • 32. Canthaxanthin--the "tanning" pill.
    Lober CW
    J Am Acad Dermatol; 1985 Oct; 13(4):660. PubMed ID: 3935691
    [No Abstract]   [Full Text] [Related]  

  • 33. Occurrence of birefringent retinal inclusions in cynomolgus monkeys after high doses of canthaxanthin.
    Goralczyk R; Buser S; Bausch J; Bee W; Zühlke U; Barker FM
    Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):741-52. PubMed ID: 9071228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aplastic anemia associated with canthaxanthin ingested for 'tanning' purposes.
    Bluhm R; Branch R; Johnston P; Stein R
    JAMA; 1990 Sep; 264(9):1141-2. PubMed ID: 2117075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Canthaxanthin.
    Gupta AK; Haberman HF; Pawlowski D; Shulman G; Menon IA
    Int J Dermatol; 1985 Oct; 24(8):528-32. PubMed ID: 3934089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orange blood syndrome.
    Hocking DR; Farrence I; Panasewycz P; Stewart M
    Med J Aust; 1981 Jan; 1(1):44. PubMed ID: 6782440
    [No Abstract]   [Full Text] [Related]  

  • 37. Canthaxanthine deposits in the eye.
    Rousseau A
    J Am Acad Dermatol; 1983 Jan; 8(1):123-4. PubMed ID: 6402526
    [No Abstract]   [Full Text] [Related]  

  • 38. Ultrahigh-resolution optical coherence tomography of canthaxanthine retinal crystals.
    Chan A; Ko TH; Duker JS
    Ophthalmic Surg Lasers Imaging; 2006; 37(2):138-9. PubMed ID: 16583635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of crystalline retinopathy after long-term therapy with beta-carotene.
    Poh-Fitzpatrick MB; Barbera LG
    J Am Acad Dermatol; 1984 Jul; 11(1):111-3. PubMed ID: 6736346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical review of canthaxanthin ('tanning pills').
    Hulisz DT; Boles GL
    Am Pharm; 1993 Aug; NS33(8):44-6. PubMed ID: 8213472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.